Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US58506Q1094
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG0065B7K59
MEDP
Medpace Holdings Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Medpace Holdings Inc
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
Tue, 16.06.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 09.06.2026       Medpace
US58506Q1094

NEW YORK, June 8, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers. This lawsuit seeks to recov...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 08.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This pres...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 08.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Me...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 08.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This pres...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 08.06.2026       Medpace
US58506Q1094

San Diego, California--(Newsfile Corp. - June 8, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, all dates inclusive (the "Class Period"), have until today, Monday, June 8, 2026 to seek appointment as...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 07.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 07.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 06.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 06.06.2026       Medpace
US58506Q1094

SAN DIEGO, June 6, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, all dates inclusive (the "Class Period"), have until this Monday, June 8, 2026 to seek appointment as lead plaintiff of...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 05.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 5, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU SUFFERED A LOSS O...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026. Medpace describes itself as a “clinical contract research organization (CRO) focused on providing scientifically-driven outsou...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 5, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 5, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 05.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sharehold...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.06.2026       Medpace
US58506Q1094

Promise vs. Reality: The Medpace Performance GapNEW YORK, June 4, 2026 /PRNewswire/ -- SueWallSt highlights the contrast between Medpace Holdings Inc.'s (NASDAQ: MEDP) promises and results. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.06.2026       Medpace
US58506Q1094

NEW YORK, June 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead p...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.06.2026       Medpace
US58506Q1094

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 04.06.2026       Medpace
US58506Q1094

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 8, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

BENSALEM, Pa., June 3, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP), C...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

Important Information Regarding Section 20(a) Individual Liability ClaimsNEW YORK, June 3, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Medpace Holdings Inc. (NASDAQ: MEDP) of a pending securities class action naming senior executives as individual defendants. Class Period: April 22, 2025 through February 9, 2026. Find out if...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 3, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sharehold...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Medpace
US58506Q1094

NEW YORK, June 2, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged to...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.06.2026       Medpace
US58506Q1094

NEW YORK, June 1, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "C...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 01.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - June 1, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 01.06.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 01.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 1, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sharehold...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 01.06.2026       Medpace
US58506Q1094

LOS ANGELES, June 1, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 01.06.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 31.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 31.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 30.05.2026       Medpace
US58506Q1094

San Diego, California--(Newsfile Corp. - May 29, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, all dates inclusive (the "Class Period"), have until Monday, June 8, 2026 to seek appointment as lead plaintiff of the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 29.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 29.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 29.05.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpace...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 28, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - May 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Medpace
US58506Q1094

NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 28.05.2026       Medpace
US58506Q1094

Notice to Pension Funds, Asset Managers, and FiduciariesNEW YORK, May 28, 2026 /PRNewswire/ -- Institutional investors holding positions in Medpace Holdings Inc. (NASDAQ: MEDP) during the period April 22, 2025 through February 9, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional i...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.05.2026       Medpace
US58506Q1094

Executive Accountability: Jesse J. Geiger Named in Securities ActionNEW YORK, May 27, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors that Jesse J. Geiger, President of Medpace Holdings Inc. (NASDAQ: MEDP), is named as a defendant in a securities class action covering purchases between April 22, 2025 and February 9, 2026. Find ou...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 27, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sharehold...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.05.2026       Medpace
US58506Q1094

LOS ANGELES, May 27, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink